Welltower Inc. Announces Q2 2026 Financial Results with SEC Filing

Second Quarter 2026 Earnings Disclosure for Healthcare REIT Operations

Welltower Inc. formally reported its Q2 2026 operating results on July 27, 2026, through a filing with securities regulators. The disclosure encompasses the three-month period ending June 30, 2026, and includes both a press release and an extensive supplemental information package. This filing fulfills Welltower’s quarterly reporting obligations under securities regulations for publicly traded companies.

Investors were provided with multiple resources for reviewing detailed financial data. The press release, submitted as Exhibit 99.1, summarized key operational results and developments. The supplemental information package, filed as Exhibit 99.2, offered additional granular metrics supporting the quarterly report. Both documents were submitted to the SEC as part of Welltower’s ongoing disclosure requirements.

Public Availability of Financial and Supplemental Data

Welltower has made the press release and supplemental information package publicly accessible at no cost via its corporate website, www.welltower.com. This transparency allows investors and interested parties to thoroughly evaluate the company’s Q2 2026 operational performance and financial condition. Providing supplemental data aligns with industry best practices among major healthcare REITs aiming for comprehensive market disclosure.

The supplemental package typically contains detailed schedules, metrics, and data expanding on the press release’s summary information. This enables investors, analysts, and stakeholders to conduct in-depth analyses of Welltower’s operational trends and financial performance drivers. Free public access to these materials supports informed investment decisions and market efficiency.

Regulatory Filing and Securities Law Classification

The Q2 2026 results were filed on Form 8-K, the current report mandated by the Securities Exchange Act of 1934 for reporting significant corporate events and financial outcomes. The filing date coincided with the press release issuance on July 27, 2026, ensuring timely disclosure in accordance with securities regulations.

Item 2.02 of the filing, which includes the press release and supplemental information, was expressly noted as not constituting a "filed" document under Section 18 of the Securities Exchange Act of 1934. This means these exhibits were furnished for informational purposes only and do not carry the same legal status as formally filed financial statements. Nonetheless, the underlying financial results remain subject to standard disclosure requirements and regulatory oversight.

Corporate Details and Market Listings

Welltower Inc., incorporated in Delaware, operates from its headquarters at 4500 Dorr Street, Toledo, Ohio 43615. The company is registered with the SEC under Commission File Number 1-8923 and holds IRS Employer Identification Number 34-1096634. Its common stock trades on the New York Stock Exchange under the ticker symbol WELL, with a par value of $1.00 per share.

In addition to common equity, Welltower has registered debt securities listed on the NYSE. These include 4.800% Notes due 2028, guaranteed by Welltower OP LLC and trading under WELL/28, and 4.500% Notes due 2034, also guaranteed by Welltower OP LLC and trading under WELL/34. These debt instruments provide additional investment options for market participants.

Healthcare Real Estate Investment Trust Operations Overview

Welltower functions as a REIT specializing in healthcare real estate ownership and management. Its portfolio generally comprises senior housing, medical office buildings, wellness centers, and other healthcare-related properties. The company’s REIT structure aims to deliver returns through rental income, asset appreciation, and strategic capital deployment within the healthcare real estate sector.

The Q2 2026 results offer insights into Welltower’s operational and financial status across its diversified portfolio. Quarterly reporting enables investors to track the company’s execution of business strategies, property management effectiveness, and return generation across market cycles. The supplemental information package provides detailed data supporting analysis of operational and financial performance.

Investor Communication and Earnings Announcement

The July 27, 2026 disclosure serves as Welltower’s official communication of its second quarter operating results. The announcement delivers audited or reviewed financial information for the period ending June 30, 2026, summarizing key results and contextualizing the quarter’s operating environment and strategic focus.

By issuing both a concise press release and an in-depth supplemental information package, Welltower caters to investors with varying analytical needs. This layered disclosure approach balances accessibility with comprehensive data provision, enhancing investor understanding.

Compliance and Filing Procedures

The Form 8-K filing was signed by Matthew McQueen, Welltower’s Chief Legal Officer, General Counsel, and Corporate Secretary, on July 27, 2026. His signature certifies that the filing was authorized and submitted in compliance with Securities and Exchange Act requirements. Using Form 8-K for quarterly results announcements is standard practice among publicly listed firms.

Welltower confirmed it is not classified as an emerging growth company under securities regulations, adhering instead to standard reporting and disclosure rules for established public companies. The filing includes interactive XBRL data to facilitate machine-readable financial and corporate information for SEC and investor use.

Information Scope and Investor Guidance

The Form 8-K filing itself did not disclose specific financial figures such as revenue or earnings per share. Investors seeking detailed numerical data must refer to the press release (Exhibit 99.1) and supplemental information package (Exhibit 99.2) available at www.welltower.com, which contain the full financial details behind the quarterly announcement.

The immediate impact of the earnings release on Welltower’s stock price was not evident from the filing alone. Investors should review trading activity and market responses from July 27, 2026, onward to evaluate market reaction. Price movements may be influenced by broader market conditions, sector trends, and investor sentiment beyond the disclosed financial results.